An antitumor tripeptide
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Tyroserleutide (trifluoroacetate salt)

Item No. 46338

Technical Information
Formal Name
L-tyrosyl-L-seryl-L-leucine, trifluoroacetate salt
Molecular Formula
C18H27N3O6 • XCF3COOH
Formula Weight
Purity
≥98%
A solid
Peptide Sequence
YSL-OH
Ethanol: Sparingly soluble: 1-10 mg/mlPBS (pH 7.2): Sparingly soluble: 1-10 mg/ml
SMILES
CC(C)C[C@@H](C(O)=O)NC([C@@H](NC([C@H](CC1=CC=C(O)C=C1)N)=O)CO)=O.O=C(O)C(F)(F)F
InChi Code
InChI=1S/C18H27N3O6.C2HF3O2/c1-10(2)7-14(18(26)27)20-17(25)15(9-22)21-16(24)13(19)8-11-3-5-12(23)6-4-11;3-2(4,5)1(6)7/h3-6,10,13-15,22-23H,7-9,19H2,1-2H3,(H,20,25)(H,21,24)(H,26,27);(H,6,7)/t13-,14-,15-;/m0./s1
InChi Key
YUBDOPZMLWMWCV-WDTSGDEMSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Tyroserleutide is an antitumor tripeptide.1,2,3 It inhibits the invasion of MHCC97-L hepatocellular carcinoma (HCC) cells at 100 µg/ml.2 Tyroserleutide induces the production of IL-1β, TNF-α, and nitric oxide (NO) in isolated mouse peritoneal macrophages and enhances the cytotoxic effect of isolated mouse peritoneal macrophages against BEL-7402 HCC and B16/F10 melanoma cells.3 It increases survival in an H22 murine hepatoma model at 10-80 µg/kg and decreases the rate of pulmonary metastasis in an MHCC97-L mouse xenograft model at 160 µg/kg.1,2 Tyroserleutide also decreases radiation-induced increases in intratumoral levels of transmembrane serine protease 4 (TMPRSS4) and hypoxia-inducible factor 1α (HIF-1α) in an MHCC97-L mouse xenograft model.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Wang, C., Ding, W., Zhao, M., et al. Studies on the large scale synthesis and anti-tumor activity of YSL. Prep. Biochem. Biotechnol. 33(3), 189-195 (2003).

    2. Jia, J.-B., Wang, W.-Q., Sun, H.-C., et al. A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice. Invest. New Drugs 29(5), 861-872 (2011).

    3. Yao, Z., Qiu, S., Wang, L., et al. Tripeptide tyroserleutide enhances the antitumor effects of macrophages and stimulates macrophage secretion of IL-1β, TNF-α, and NO in vitro. Cancer Immunol. Immunother. 55(1), 56-60 (2006).